Merck & Co., Inc. Logo

Merck & Co., Inc.

A global biopharma developing innovative medicines, vaccines, and animal health products.

MRK | F

Overview

Corporate Details

ISIN(s):
DE0006599905 (+71 more)
LEI:
4YV9Y5M8S0BRK1RP0397
Country:
United States of America
Address:
126 EAST LINCOLN AVENUE, 7065 RAHWAY
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Merck & Co., Inc. is a global, research-intensive biopharmaceutical company dedicated to developing innovative health solutions. With a history spanning over 130 years, the company discovers, develops, manufactures, and markets a broad range of products, including prescription medicines, vaccines, biologic therapies, and animal health products. Merck focuses on scientific innovation to address significant global health challenges, leveraging a robust research pipeline and extensive clinical trials. The company is a leader in various therapeutic areas, particularly oncology and vaccines, aiming to save and improve lives worldwide.

Social Media

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-11-28 14:26
Declaration of Voting Results & Voting Rights Announcements
English 80.9 KB
2025-11-24 10:50
Declaration of Voting Results & Voting Rights Announcements
English 78.5 KB
2025-11-20 14:25
Declaration of Voting Results & Voting Rights Announcements
English 78.5 KB
2025-11-17 00:00
Regulatory Filings
Q3 statement / Q3 financial report 2025
English 489.3 KB
2025-10-24 15:20
Declaration of Voting Results & Voting Rights Announcements
English 78.0 KB
2025-10-23 17:37
Declaration of Voting Results & Voting Rights Announcements
English 78.0 KB
2025-10-21 09:10
Declaration of Voting Results & Voting Rights Announcements
English 78.0 KB
2025-10-17 18:51
Declaration of Voting Results & Voting Rights Announcements
English 78.0 KB
2025-10-16 09:03
Declaration of Voting Results & Voting Rights Announcements
English 77.8 KB
2025-10-14 08:31
Declaration of Voting Results & Voting Rights Announcements
English 77.8 KB
2025-09-01 00:00
Interim / Quarterly Report
Half-yearly financial report 2025
English 999.9 KB
2025-08-13 17:39
Declaration of Voting Results & Voting Rights Announcements
English 81.2 KB
2025-08-05 23:02
Declaration of Voting Results & Voting Rights Announcements
English 81.2 KB
2025-07-14 15:01
Declaration of Voting Results & Voting Rights Announcements
English 81.2 KB
2025-07-08 18:21
Declaration of Voting Results & Voting Rights Announcements
English 81.2 KB

Automate Your Workflow. Get a real-time feed of all Merck & Co., Inc. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Merck & Co., Inc.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Merck & Co., Inc. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

co.don AG Logo
Develops personalized cartilage cell transplants for minimally invasive joint repair.
Germany
CNW
Coeptis Therapeutics Holdings, Inc. Logo
Develops cell therapy platforms for cancer, autoimmune, and infectious diseases.
United States of America
COEP
COGNITION THERAPEUTICS INC Logo
Clinical-stage biopharma developing small-molecule drugs for Alzheimer's and dementia.
United States of America
CGTX
Coherus Oncology, Inc. Logo
Commercial-stage biopharma developing immuno-oncology therapies for hard-to-treat cancers.
United States of America
CHRS
COLLEGIUM PHARMACEUTICAL, INC Logo
Develops and commercializes abuse-deterrent medications for responsible chronic pain management.
United States of America
COLL
CollPlant Biotechnologies Ltd Logo
Develops rhCollagen for 3D bioprinting of tissues for regenerative & aesthetic medicine.
United States of America
CLGN
Compass Therapeutics, Inc. Logo
A clinical-stage oncology firm developing antibody therapies that engage the immune system.
United States of America
CMPX
Compugen Ltd. Logo
Uses AI to discover and develop novel antibody immunotherapies for hard-to-treat cancers.
Israel
CGEN
COMPUGEN LTD Logo
AI-driven discovery of novel cancer immunotherapies for treatment-resistant patients.
United States of America
CGEN
Connect Biopharma Holdings Ltd Logo
Develops immune modulators for T cell-driven inflammatory diseases like asthma and COPD.
United States of America
CNTB

Talk to a Data Expert

Have a question? We'll get back to you promptly.